MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Home・Stock List・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Closed

SectorHealthcare

33.75 -0.21

Buy Sell

Overview

Share price change

24h

Current

Min

33.24

Max

33.9

Key metrics
By Trading Economics
Income	-14M -81M
Sales	75K 75K
EPS	-1.22
Profit margin	-108,422.667
Employees	198
EBITDA	-7.8M -81M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+60.91% upside

Dividends
By Dow Jones
Next Earnings	6 May 2026

Market Stats
By TradingEconomics
Market Cap	941M 2.6B
Previous open	33.96
Previous close	33.75

News Sentiment

By Acuity

100%

339 / 348 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.91 / 20.63 Support & Resistance

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

15 Apr 2026, 23:14 UTC

Earnings

Battery Maker CATL First-Quarter Net Rose on Strong Demand

15 Apr 2026, 23:14 UTC

Earnings

Battery Maker CATL First Quarter Net Rose On Strong Demand

15 Apr 2026, 17:13 UTC

Major Market Movers

Tesla Shares Rise on Completion of AI5 Chip Design Process

15 Apr 2026, 23:39 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

15 Apr 2026, 23:35 UTC

Market Talk

Major News Events

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

15 Apr 2026, 22:41 UTC

Earnings

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

15 Apr 2026, 22:38 UTC

Earnings

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

15 Apr 2026, 22:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Apr 2026, 22:15 UTC

Market Talk

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

15 Apr 2026, 22:14 UTC

Earnings

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

15 Apr 2026, 22:12 UTC

Earnings

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

15 Apr 2026, 22:11 UTC

Earnings

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

15 Apr 2026, 22:11 UTC

Earnings

Lens Technology Swings to Loss in 1Q>300433.SZ

15 Apr 2026, 22:07 UTC

Earnings

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

15 Apr 2026, 21:34 UTC

Acquisitions, Mergers, Takeovers

Skild AI Acquires Zebra Technologies' Robotics Automation Business

15 Apr 2026, 21:29 UTC

Hot Stocks

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

15 Apr 2026, 20:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

15 Apr 2026, 20:30 UTC

Earnings

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

15 Apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 Apr 2026, 20:06 UTC

Market Talk

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

15 Apr 2026, 19:46 UTC

Earnings

Acquisitions, Mergers, Takeovers

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

15 Apr 2026, 19:25 UTC

Market Talk

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

15 Apr 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

15 Apr 2026, 18:58 UTC

Market Talk

Major News Events

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

15 Apr 2026, 18:11 UTC

Acquisitions, Mergers, Takeovers

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

15 Apr 2026, 17:45 UTC

Acquisitions, Mergers, Takeovers

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

15 Apr 2026, 16:58 UTC

Earnings

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

15 Apr 2026, 16:52 UTC

Earnings

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

15 Apr 2026, 16:46 UTC

Market Talk

Major News Events

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

15 Apr 2026, 16:37 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

60.91% upside

12 Months Forecast

Average 54.5 USD 60.91%

High 90 USD

Low 24 USD

Based on 11 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Celldex Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.